Hologic Showcases Advances across the Continuum of Breast Health at ECR 2022

Rhea-AI Summary

Hologic, Inc. (NASDAQ: HOLX) is set to showcase its innovative breast and skeletal health solutions at the European Congress of Radiology in Vienna from July 13-17. The company aims to address challenges in early detection caused by pandemic delays. Attendees can explore Hologic's 3D Mammography™ technology and participate in scientific talks at the Scientific Innovation Hub. Highlights from the inaugural Hologic Global Women’s Health Index will also be shared, focusing on women's health perspectives. This event underscores Hologic's commitment to improving women's health.

Positive

• Showcasing innovative 3D Mammography™ technology at the European Congress of Radiology.
• Focus on addressing delays in early detection due to the pandemic.
• Scientific Innovation Hub featuring expert-led talks on breast health.
• Presentation of findings from the Global Women’s Health Index, enhancing brand visibility.

Negative

• No specific financial metrics or sales forecasts provided, leaving uncertainty about commercial success.

--Global Leader in Women's Health Highlights Importance of Timely and Accurate Diagnosis--

MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX) will showcase their comprehensive portfolio of breast and skeletal health solutions at the annual European Congress of Radiology (ECR) in Vienna, Austria from July 13-17.

The pioneer behind 3D Mammography™ technology, Hologic will provide attendees with an interactive experience that underscores a commitment to innovation through advancements in breast screening, surgery, biopsy and ultrasound solutions. As visitors explore the clinically proven, integrated solutions across Hologic’s Breast Health Continuum of Care, they can understand how these technologies support the early detection and diagnostic needs of patients.

“We’re thrilled to return to ECR to showcase how Hologic’s product portfolio can support the needs of radiologists and patients throughout the continuum of breast health,” said Tanja Brycker, Vice President, Strategic Development, Breast and Skeletal Health and Gynecological Surgical Solutions at Hologic. “Our portfolio is designed to tackle today’s biggest challenges to early detection‚ such as pandemic delays and radiology backlogs, in order to help remove these barriers to diagnosis and treatment.”

Hologic’s ECR presence will also include the Scientific Innovation Hub, where a wide variety of scientific talks led by experts in the field will be hosted throughout the event. Medical education sessions will focus on current topics, ranging from personalization in breast cancer detection, contrast-enhanced mammography in clinical practice, trends and practices in biopsy and lesion localization, and ultrasound in clinical practice for breast and liver. A full list of sessions will be available at the Hub.

Additionally, the booth will feature findings from the Hologic Global Women’s Health Index, developed in collaboration with the Gallup World Poll. This multiyear, comprehensive global survey provides an understanding of women’s perspectives and experiences on key health topics. Throughout ECR, Hologic will share highlights from the inaugural survey released in September 2021, so attendees can learn about the state of women's health in their region.

For more information, or to register for a scientific session, stop by Hologic’s booth in Foyer O on the first floor of the ACV Main Congress building.

About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

Hologic and 3D Mammography are trademarks and/or registered trademarks of Hologic, Inc., and/or its subsidiaries in the United States and/or other countries.

Forward-Looking Statements

This news release may contain forward-looking information that involves risks and uncertainties, including statements about the use of Hologic products. There can be no assurance these products will achieve the benefits described herein or that such benefits will be replicated in any particular manner with respect to an individual patient, as the actual effect of the use of the products can only be determined on a case-by-case basis. In addition, there can be no assurance that these products will be commercially successful or achieve any expected level of sales. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such data or statements are based.

SOURCE: Hologic, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220713005115/en/

Jane Mazur

+1 508.263.8764 (direct)

jane.mazur@hologic.com

Source: Hologic, Inc.

FAQ

What will Hologic showcase at the European Congress of Radiology 2023?

Hologic will showcase its breast and skeletal health solutions, including 3D Mammography™ technology.

When is the European Congress of Radiology 2023?

The event will take place from July 13-17, 2023, in Vienna, Austria.

What is the purpose of Hologic's participation in ECR?

Hologic aims to address early detection challenges and showcase innovations in women's health.

What insights will be shared at the Scientific Innovation Hub?

The hub will feature talks on topics like breast cancer detection and clinical practices in ultrasound.

What is the Hologic Global Women’s Health Index?

It is a comprehensive survey that provides insights into women's health perspectives, first released in September 2021.